NASDAQ
Enlivex Therapeutics Ltd. (ENLV) has a interest coverage ratio of -1153.85x as of Friday, May 29, 2026. This represents a 37.43% decrease compared to its 12-month average of -839.61x. The interest coverage ratio measures how easily a company can pay interest on its outstanding debt from operating earnings.
No price data available for this timeframe.